New oral anticoagulants: an alternative to warfarin.
New agents have been introduced for the prevention of inappropriate thrombosis in the vascular tree and the heart. This article reviews, compares and contrasts the newer agents which inhibit activated factor X (Xa) or activated factor II (thrombin).